FDA NDC Directory
Recently listed NDCs
Finished products in the FDA NDC Directory with the newest marketing start dates — new brands and generics, and new strengths or packages of existing products.
A listing is not an approval
The date shown is the marketing start date the labeler reported. Many new listings are generics, repackaged or relabeled products, or new package sizes. The marketing category (NDA, ANDA, BLA) on each product page says under what authority it is marketed.
Newest first
831 listings in the last 90 days
| Product | Strength | Form · route | Labeler | Listed | Product NDC |
|---|---|---|---|---|---|
| Prucalopride | Prucalopride succinate 2 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Inc. | Jul 31, 2026 | 62332-078 |
| Atropineatropine sulfate | Atropine sulfate 10 mg/mL | Solution/ dropsOphthalmic | Gland Pharma Limited | Jul 31, 2026 | 68083-669 |
| Atropineatropine sulfate | Atropine sulfate 10 mg/mL | Solution/ dropsOphthalmic | Gland Pharma Limited | Jul 31, 2026 | 68083-670 |
| Atropineatropine sulfate | Atropine sulfate 10 mg/mL | Solution/ dropsOphthalmic | Gland Pharma Limited | Jul 31, 2026 | 68083-671 |
| Ciprofloxacin Hydrochloride | Ciprofloxacin hydrochloride 500 mg/1 | Tablet, Film coatedOral | Preferred Pharmaceuticals Inc | Jul 31, 2026 | 68788-4177 |
| Glipizide | Glipizide 5 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | Jul 31, 2026 | 68788-4178 |
| Amoxicillin and Clavulanate Potassium | Amoxicillin 400 mg/5mL; Clavulanic acid 57 mg/5mL | Powder, For suspensionOral | Preferred Pharmaceuticals Inc. | Jul 31, 2026 | 68788-4179 |
| Lorazepam | Lorazepam 1 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | Jul 31, 2026 | 68788-4180 |
| Methocarbamol | Methocarbamol 500 mg/1 | Tablet, Film coatedOral | Medcore LLC | Jul 31, 2026 | 82461-722 |
| Methocarbamol | Methocarbamol 750 mg/1 | Tablet, Film coatedOral | Medcore LLC | Jul 31, 2026 | 82461-723 |
| Morphine Sulfate | Morphine sulfate 15 mg/1 | TabletOral | St. Mary's Medical Park Pharmacy | Jul 30, 2026 | 60760-893 |
| Dextromethorphan Hydrobromide and Quinidine Sulphate | Dextromethorphan hydrobromide 20 mg/1; Quinidine sulfate 10 mg/1 | CapsuleOral | Sun Pharmaceutical Industries, Inc. | Jul 30, 2026 | 63304-650 |
| doxycycline | Doxycycline hyclate 100 mg/1 | CapsuleOral | Preferred Pharmaceuticals Inc. | Jul 30, 2026 | 68788-4176 |
| prazosin hydrochloride | Prazosin hydrochloride 1 mg/1 | CapsuleOral | REMEDYREPACK INC. | Jul 30, 2026 | 70518-4712 |
| Tramadol Hydrochloride | Tramadol hydrochloride 50 mg/1 | Tablet, CoatedOral | REMEDYREPACK INC. | Jul 30, 2026 | 70518-4713 |
| Auvelitydextromethorphan hydrobromide, bupropion hydrochloride | — | Kit | Axsome Therapeutics, Inc. | Jul 30, 2026 | 81968-453 |
| Hydrocortisone Acetate Cream | Hydrocortisone acetate 20 mg/g | CreamTopical | Allegis Pharmaceuticals, Inc. | Jul 29, 2026 | 28595-050 |
| ziprasidone | Ziprasidone hydrochloride 40 mg/1 | CapsuleOral | REMEDYREPACK INC. | Jul 29, 2026 | 70518-4711 |
| sugammadex | Sugammadex sodium 200 mg/2mL | Injection, SolutionIntravenous | Fosun Pharma USA Inc. | Jul 29, 2026 | 72266-268 |
| sugammadex | Sugammadex sodium 500 mg/5mL | Injection, SolutionIntravenous | Fosun Pharma USA Inc. | Jul 29, 2026 | 72266-269 |
| Mifepristone | Mifepristone 200 mg/1 | TabletOral | Evita Solutions LLC | Jul 29, 2026 | 84670-014 |
| Sugammadex | Sugammadex sodium 200 mg/2mL | InjectionIntravenous | B. Braun Medical Inc. | Jul 28, 2026 | 0264-8200 |
| Sugammadex | Sugammadex sodium 100 mg/mL | InjectionIntravenous | Hikma Pharmaceuticals USA Inc. | Jul 28, 2026 | 0641-6270 |
| Sugammadex | Sugammadex sodium 200 mg/2mL | Injection, SolutionIntravenous | Sandoz Inc | Jul 28, 2026 | 0781-3468 |
| Sugammadex | Sugammadex sodium 500 mg/5mL | Injection, SolutionIntravenous | Sandoz Inc | Jul 28, 2026 | 0781-3469 |